Literature DB >> 18789066

Prognostic factor of adult patients with atopic dermatitis.

Norito Katoh1, Shinya Hirano, Saburo Kishimoto.   

Abstract

The increased prevalence of atopic dermatitis (AD) in adults in recent decades suggests that dermatologists may be expected to estimate the prognosis of adult patients with AD when they visit as new patients. We therefore evaluated the change in the extent of involvement and analyzed the factors that contribute to the prognosis of adult AD. A retrospective chart review was performed for 65 adults patients (median age at first visit, 25 years) with AD who had been followed monthly for over 10 years. The median area of involvement at first visit was 19%. The area of the eruptions and peripheral eosinophil counts decreased significantly in the fifth and 10th years with standard treatment. The values of immunoglobulin (Ig)E were also reduced after 10 years. Patients with high values of serum total IgE and peripheral eosinophil count, and long duration of AD had wide areas of eruptions 10 years after the first visit. Total IgE had the highest correlation with area of involvement after 10 years. Although the prognosis of adult AD is not poor, patients with high IgE values are expected to have ongoing eczema with wide distribution after 10 years of follow up.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18789066     DOI: 10.1111/j.1346-8138.2008.00507.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  5 in total

1.  Prevalence and clinical features of adult atopic dermatitis in tertiary hospitals of China.

Authors:  Xin Wang; Xiao-Dong Shi; Lin-Feng Li; Ping Zhou; Yi-Wei Shen; Qing-Kun Song
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

2.  Omalizumab usage in chronic urticaria and atopic dermatitis: data from South-East province of Turkey.

Authors:  Hülya Nazik; Mehmet Kamil Mülayim; Perihan Öztürk
Journal:  Postepy Dermatol Alergol       Date:  2019-12-30       Impact factor: 1.837

Review 3.  Emerging Nanomedicines for the Treatment of Atopic Dermatitis.

Authors:  Khushali Parekh; Tejal A Mehta; Namdev Dhas; Pavan Kumar; Amirali Popat
Journal:  AAPS PharmSciTech       Date:  2021-01-24       Impact factor: 3.246

4.  Evaluation of standard treatments for managing adult Japanese patients with inadequately controlled moderate-to-severe atopic dermatitis: Two-year data from the ADDRESS-J disease registry.

Authors:  Norito Katoh; Hidehisa Saeki; Yoko Kataoka; Takafumi Etoh; Satoshi Teramukai; Hiroki Takagi; Hiroyuki Fujita; Marius Ardeleanu; Elena Rizova; Kazuhiko Arima
Journal:  J Dermatol       Date:  2022-06-17       Impact factor: 3.468

5.  Adult onset atopic dermatitis: Under-recognized or under-reported?

Authors:  Amrinder Jit Kanwar; Tarun Narang
Journal:  Indian Dermatol Online J       Date:  2013-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.